Infrequent presence of anti-c-Myc antibodies and absence of c-Myc oncoprotein in sera from lung cancer patients

Oncology

Volumn 56, Issue 2, 1999, Pages 129-133

  Yamamoto, Akiyoshi ^a   Shimizu, Eiji ^a   Takeuchi, Eiji ^a   Houchi, Hitoshi ^a   Doi, Hiroyuki ^b   Bando, Hiroyasu ^c   Ogura, Takeshi ^d   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Kochi Municipal Hospital   (Japan)

^c TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d TONEYAMA NATIONAL HOSPITAL   (Japan)

Author keywords

Auto antibody; c myc; Immunoblotting; Lung cancer; Oncogene

Indexed keywords

AUTOANTIBODY; CANCER ANTIBODY; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; MYC PROTEIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXON; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOBLOTTING; INCIDENCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; ONCOGENE C MYC; PRIORITY JOURNAL; SERODIAGNOSIS;

ADULT; AGED; ANTIBODIES, NEOPLASM; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 0032998465     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011953     Document Type: Article

References (22)

1. Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF, Minna JD: p53: A frequent target for genetic abnormalities in lung cancer. Science 1989;246:491-494.
2. Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988;241: 353-357.
3. Shimizu E, Coxon A, Otterson GA, Steinberg SM, Kratzke RA, Kim YW, Fedorko J, Oie H, Johnson BE, Mulshine JL, Minna JD, Gazdar AF, Kaye FJ: RB protein status and clinical corrrelation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene 1994;9: 2441-2448.
4. Rodenhuis S, Slebos RJ, Boot AJM, Evers SG, Mooi WJ, Wagenaar SS, van Bodegom PC, Bos JL: Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res 1988;48: 5738-5741.
5. Yokota J, Wada M, Yoshida T, Noguchi M, Terasaki T, Shimosato Y, Sugimura T, Terada M: Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. Oncogene 1988;2: 607-611.
6. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 1994;9:3375-3378.
7. Pupa SM, Ménard S, Andreola S, Colnaghi MI: Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients. Cancer Res 1993;53:5864-5866.
8. Peyrat JP, Bonneterre J, Lubin R, Vanlemmens L, Fournier J, Soussi T: Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer. Lancet 1995;345:621-622.
9. Takahashi M, Chen W, Byrd DR, Disis ML, Huseby ES, Qin H, McCahill L, Nelson H, Shimada H, Okuno K, Yasutomi M, Peace DJ, Cheever MA: Antibody to ras proteins in patients with colon cancer. Clin Cancer Res 1995; 1:1071-1077.
10. Trivers GE, Cawley HL, DeBenedetti VMG, Hollstein M, Marion MJ, Bennett WP, Hoover ML, Prives CC, Tamburro CC, Harris CC: Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. J Natl Cancer Inst 1995;87:1400-1407.
11. Lubin R, Zalcman G, Bouchet L, Trédaniel J, Legros Y, Cazals D, Hirsch A, Soussi T: Serum p53 antibodies as early markers of lung cancer. Nature Med 1995;1:701-702.
12. Trivers GE, DeBenedetti VMG, Cawley HL, Caron G, Harrington AM, Bennett WP, Jett JR, Colby TV, Tazelaar H, Pairolero P, Miller RD, Harris CC: Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer. Clin Cancer Res 1996;2:1767-1775.
13. Yamamoto A, Shimizu E, Ogura T, Sone S: Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients. Int J Cancer 1996;69:283-289.
14. Johnson BE: The role of MYC, JUN, and FOS oncogenes in human lung cancer, in Pass HI, Mitchell JB, Johnson DH, Turrisi AT (eds): Lung Cancer. Philadelphia, Lippincott, 1996, pp 83-98.
15. Shiraishi M, Noguchi M, Shimosato Y, Sekiya T: Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res 1989;49:6474-6479.
16. Smith DB, Johnson KS: Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988;67:31-40.
17. Watt R, Stanton LW, Marcu KB, Gallo RC, Croce CM, Rovera G: Nucleotide sequence of cloned cDNA of human c-myc oncogene. Nature 1983;303:725-728.
18. DePinho RA, Hatton KS, Tesfaye A, Yancopoulos GD, Alt FW: The human myc gene family: Structure and activity of L-myc and L-myc pseudogene. Genes Dev 1987;1:1311-1326.
19. Kaye F, Battey J, Nau M, Brooks B, Seifter E, Greue JD, Birrer M, Sausville E, Minna J: Structure and expression of the human L-myc gene reveal a complex pattern of alternate mRNA processing. Mol Cell Biol 1988;8:186-195.
20. Ben-Mahrez K, Thierry D, Sorokine I, Danna-Muller A, Kohiyama M: Detection of circulating antibodies against c-myc protein in cancer patient sera. Br J Cancer 1988;57:529-534.
21. Ben-Mahrez K, Sorokine I, Thierry D, Kawasumi T, Ishii S, Salmon R, Kohiyama M: Circulating antibodies against c-myc oncogene product in sera of colorectal patients. Int J Cancer 1990;46:35-38.
22. Dosaka-Akita H, Akie K, Hiroumi H, Kinoshita I, Kawakami Y, Murakami A: Inhibition of proliferation of L-myc antisense DNA for the translational initiation site in human small cell lung cancer. Cancer Res 1995;55:1559-1564.